World Health Assembly (WHA)
WHO funding A replenishment mechanism for WHO?

As the World Health Organization’s Executive Board gets ready to hold its 152nd meeting, the budget and financing of the United Nations health agency remain at the top of the agenda

Health workers Building international norms for protecting health workers 

An expert roundtable consisting of health workers and trade unionists discussed the role of international legal norms in protecting health workers, and whether these can be improved by a new WHO instrument

Is corporate lobbying influencing US positions at the WHO?

A new report shows that US corporations and their umbrella organizations are allocating increasing amounts of money for shaping delegates’ interventions at WHO, with potentially disastrous effects on health

IP at World Health Assembly Private monopolies hinder progress on public health: intellectual property at the 75th World Health Assembly

Obstruction by pharmaceutical companies from the Global North and misuse of monopoly privileges continue to slow down research into new vaccines and medicines, with disastrous effects for people’s health in the Global South. Discussions at the 75th World Health Assembly did little to address this

Obesity WHA Obesity pandemic at the World Health Assembly: when the unhinged market feeds disease

This year’s World Health Assembly prominently featured discussions obesity. However, the implementation of serious policies to deal with the issue is being undermined by the multi-stakeholder approach, which is letting industries influence the conversation. 

Sustainable financing Sustainably financing the World Health Organization

Sustainable financing of the WHO was one of the most anticipated topics of the 75th World Health Assembly. Although progress has been made through efforts of a designated working group, worries remain that the planned increase will not be enough to meet actual needs

World Health Assembly World Health Assembly falls short of insulating food and alcohol plans from commercial interests

Without stronger action to counter the influence of transnational alcohol and food companies, industry-propelled health harm will continue to persist

Trade unions and civil society ask WHO members for stronger commitment to health workers’ rights

Baba Aye from Public Services International (PSI) looks back at the major discussion points and highlights of the 75th World Health Assembly

What will happen to pandemic response after WHO and WTO meetings?

Lauren Paremoer from the People’s Health Movement South Africa talks about how the recent World Health Assembly and the Ministerial Conference of the WTO will have a major role in deciding the course of the response in case of new health emergencies and pandemics.

WHO to hold first in-person assembly since onset of pandemic

The World Health Assembly is going to discuss topics of great relevance for our times, but in order to make necessary change the WHO must step up and recognize the fundamental issues plaguing global governance of health

The Pandemic Treaty Proposal expands global health inequities

The World Health Assembly Special Session in November will be considering the benefits of developing a new international instrument on pandemic preparedness and response. Rich countries are using the opportunity to sideline discussions on equity in public health

Access to insulin: A tale of 100 years of disparity

A century after the discovery of insulin, quality-assured access remains hindered by high prices. The WHO resolution for transparency in pricing of insulin aims at dealing with Big Pharma market monopoly